Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

(FluBu) conditioning prior to allogeneic hematopoietic stem cell transplant (HSCT).

myeloproliferative disorder
blast cells
hla-a
fludarabine
secondary acute myeloid leukemia
  • 6 views
  • 24 Feb, 2021
  • 1 location
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated donor in persons 0-70 years of age diagnosed with dyskeratosis

alemtuzumab
reticulocyte count
total body irradiation
ejection fraction
nop10
  • 24 views
  • 25 Jan, 2021
  • 1 location
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or, fludarabine/busulfan for

lymphoblasts
myeloproliferative disorder
autologous transplant
cebpa
autograft
  • 58 views
  • 27 Jan, 2021
  • 1 location
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

patients with newly diagnosed acute myeloid leukemia not eligible for intensive chemotherapy (thus not eligible for an allogeneic hematopoietic stem cell transplant.

carbon monoxide
ara-c
leukapheresis
hemolysis
direct bilirubin
  • 17 views
  • 01 Mar, 2021
  • 156 locations
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Patients undergoing either an autologous or allogeneic hematopoietic stem cell transplant (HSCT) and receiving preparative chemotherapy experience a considerable amount of chemotherapy-induced

butyrophenone
dexamethasone
antiemetics
nausea
preparative regimen
  • 1 views
  • 26 Feb, 2021
  • 1 location
ONC 201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

This is a single-center pilot study of 20 patients with AML/MDS. Eligible patients will be enrolled following an informed consent between 6-20 weeks after allogeneic hematopoietic stem cell

minimal residual disease
blast cells
blood transfusion
TP53
aml/mds
  • 9 views
  • 23 Jan, 2021
  • 1 location
Cemiplimab in AlloSCT/SOT Recipients With CSCC

In this research study, Cemiplimab is being evaluated as a treatment for advanced cutaneous squamous cell carcinoma in participants who have previously received an allogeneic hematopoietic stem

acute gvhd
prednisone
serum follicle stimulating hormone
carcinoma
cemiplimab
  • 0 views
  • 25 Jan, 2021
Combination Chemotherapy Total Body Irradiation and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

This pilot phase I trial studies the side effects of combination chemotherapy, total body irradiation, and donor blood stem cell transplant in treating patients with secondary myelofibrosis. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them …

  • 31 views
  • 24 Jan, 2021
  • 2 locations
CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

This pilot trial studies the side effects and how well CBM588 works in improving clinical outcomes in patients who have undergone donor hematopoietic stem cell transplant. Gut microbiota (formerly called gut flora) is the name given to the microbe (bacteria) population living in the intestine. Gut bacteria help the body …

karnofsky performance status
cell transplantation
hematologic disorders
blood disorder
  • 14 views
  • 28 Jan, 2021
  • 1 location
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

This phase I/II trial studies the side effects and best dose of bendamustine when given with or without cyclophosphamide in preventing graft versus host disease (GVHD) in patients undergoing stem cell transplant. Drugs used in chemotherapy, such as bendamustine and cyclophosphamide, work in different ways to stop the growth of …

hematologic malignancy
cancer
filgrastim
graft versus host disease
fludarabine
  • 6 views
  • 29 Jan, 2021
  • 1 location